The U.S. Court of Appeals for the Second Circuit on Thursday upheld the convictions of two former executives who engineered a secret kickback scheme to defraud drugmaker Valeant Pharmaceuticals International.

A three-judge panel of the Manhattan-based appeals court said there was “ample evidence” to support the 2018 convictions of Gary Tanner, the ex-Valeant executive, and former Philidor Rx Services CEO Andrew Davenport on four charges, including fraud and conspiracy to commit money laundering.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]